embryonic stem cell patent

There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cell patent approaches. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has dealt a severe blow to stem cell science in Europe. The European Court of Justice ruled today that methods involving not just human embryos but also existing human ESC lines, cannot be patented. Remarkably, this ruling impacts all 27 members of the …Read More